Related Experiment Video
Updated: Sep 3, 2026

Analysis of Apoptosis in Zebrafish Embryos by Whole-mount Immunofluorescence to Detect Activated Caspase 3
Published on: December 20, 2013
In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes
Abstract:
Caspase-3 is essential for Fas-mediated apoptosis in vitro. We investigated the role of caspase-3 in Fas-mediated cell death in vivo by injecting caspase-3-deficient mice with agonistic anti-Fas Ab. Wild-type controls died rapidly of fulminant hepatitis, whereas the survival of caspase-3-/- mice was increased due to a delay in hepatocyte cell death. Bcl-2 expression in the liver was dramatically decreased in wild-type mice following anti-Fas injection, but was unchanged in caspase-3-/- mice. Hepatocytes from anti-Fas-injected wild-type, but not caspase-3-/-, mice released cytochrome c into the cytoplasm. Western blotting confirmed the lack of caspase-3-mediated cleavage of Bcl-2. Presumably the presence of intact Bcl-2 in caspase-3-/- hepatocytes prevents the release of cytochrome c from the mitochondria, a required step for the mitochondrial death pathway. We also show by Western blot that Bcl-xL, caspase-9, caspase-8, and Bid are processed by caspase-3 in injected wild-type mice but that this processing does not occur in caspase-3-/- mice. This study thus provides novel in vivo evidence that caspase-3, conventionally known for its downstream effector function in apoptosis, also modifies Bcl-2 and other upstream proteins involved in the regulation of Fas-mediated apoptosis.
Insights
Caspase-3 deficiency delays Fas-mediated hepatocyte death in vivo. Intact Bcl-2 in caspase-3-/- mice prevents cytochrome c release, highlighting caspase-3
Area of Science:
- Molecular Biology
- Immunology
- Cell Death Research
Background:
- Caspase-3 is a key executioner in apoptosis in vitro.
- Its precise role in Fas-mediated apoptosis in vivo remains incompletely understood.
- Fas-mediated apoptosis is critical for immune regulation and tissue homeostasis.
Purpose of the Study:
- To investigate the in vivo role of caspase-3 in Fas-mediated hepatocyte apoptosis.
- To determine if caspase-3 regulates upstream apoptotic proteins in Fas signaling.
Main Methods:
- Administration of agonistic anti-Fas antibody to wild-type and caspase-3-deficient mice.
- Assessment of hepatocyte cell death, survival rates, and liver injury.
- Western blot analysis of Bcl-2, Bcl-xL, caspase-9, caspase-8, Bid, and cytochrome c.
- Analysis of protein processing and subcellular localization of cytochrome c.
Main Results:
- Caspase-3 deficient mice exhibited delayed hepatocyte death and increased survival following anti-Fas Ab injection.
- Wild-type mice showed decreased Bcl-2 expression and cytochrome c release, unlike caspase-3 deficient mice.
- Caspase-3 deficiency prevented the cleavage of Bcl-2, Bcl-xL, caspase-9, caspase-8, and Bid.
Conclusions:
- Caspase-3 plays a crucial role in regulating Fas-mediated apoptosis in vivo.
- Beyond its effector function, caspase-3 processes upstream regulatory proteins like Bcl-2, impacting mitochondrial pathways.
- This study reveals a novel upstream regulatory function for caspase-3 in Fas-mediated cell death.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy

